136 results
6-K
EX-10.1
BLRX
Bioline Rx Ltd
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
and as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i
424B5
BLRX
Bioline Rx Ltd
1 Apr 24
Prospectus supplement for primary offering
10:30am
and there can be no assurance that the market value of warrants will equal or exceed their imputed offering price. There can be no assurance that the market … . The offered securities may or may not be listed on a national securities exchange. No assurance can be given that there will be a market
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
be no assurance that we will generate significant revenue or as to the timing of any such revenue, and we may not achieve profitability for several years … , prospects or results of operations. There is no assurance that we would be able to take any of such actions, or that such actions would permit us meet
20-F/A
2023 FY
EX-12.2
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
20-F/A
2023 FY
EX-12.1
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
F-3
24lv93
29 Dec 23
Shelf registration (foreign)
4:15pm
6-K
EX-99
rs8018fcsof2dg
30 Aug 23
Current report (foreign)
6:45am
6-K
EX-99
gqh njcfbex0
15 Nov 22
BioLineRx Reports Third Quarter 2022 Financial Results and Recent Corporate
7:07am
6-K
EX-10.1
v1jw t6yrw1e
21 Sep 22
Current report (foreign)
8:00am
424B5
254w4
20 Sep 22
Prospectus supplement for primary offering
4:30pm
6-K
EX-99
8ms4gomo4w7i 51r
15 Sep 22
Current report (foreign)
8:39am
20-F/A
EX-12.2
072w1ym5
9 Sep 22
Annual report (foreign) (amended)
4:15pm
20-F/A
EX-12.1
byh3gcf
9 Sep 22
Annual report (foreign) (amended)
4:15pm